Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2026-01-24 @ 8:09 AM
Study NCT ID:
NCT00720304
Status:
COMPLETED
Last Update Posted:
2024-08-22
First Post:
2008-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Organization: